A case of Lafora's disease associated with cardiac arrhythmia
- PMID: 10593553
- DOI: 10.1177/088307389901401111
A case of Lafora's disease associated with cardiac arrhythmia
Abstract
Progressive myoclonic epilepsies are rare, genetically transmitted diseases characterized by epileptic seizures, myoclonus, and progressive neurologic deterioration. Unverricht-Lundborg disease, Lafora's disease, neuronal ceroid lipofuscinosis, mitochondrial disorders, and sialidosis are included in this group. Lafora's disease is a progressive disorder of the central nervous system with onset in the late first or second decade of life and is inherited in an autosomal-recessive pattern. The first clinical manifestation is generalized tonic-clonic seizures, myoclonus, or both, usually seen between the ages of 11 and 18 years. The other clinical manifestations are progressive dementia and limb ataxia. Diagnosis is based on showing the typical inclusions in the brain, liver, skin, or muscle tissue specimens. The case of a 6-year-old male patient, who was admitted with the clinical findings of third-degree atrioventricular block and dementia and eventually diagnosed with Lafora's disease, is presented.
Similar articles
-
Lafora's disease: towards a clinical, pathologic, and molecular synthesis.Pediatr Neurol. 2001 Jul;25(1):21-9. doi: 10.1016/s0887-8994(00)00276-9. Pediatr Neurol. 2001. PMID: 11483392 Review.
-
[Progressive myoclonic epilepsy type Lafora].J Med Liban. 2001 May-Jun;49(3):170-2. J Med Liban. 2001. PMID: 12187920 French.
-
Unusual presentation of Lafora's disease.J Child Neurol. 2003 Jul;18(7):499-501. doi: 10.1177/08830738030180070901. J Child Neurol. 2003. PMID: 12940657
-
[Progressive myoclonic epilepsy secondary to Lafora's body disease].Medicina (B Aires). 2018;78(6):436-439. Medicina (B Aires). 2018. PMID: 30504111 Spanish.
-
[Lafora's disease (EPM2)].Rev Neurol (Paris). 2007 Jan;163(1):47-53. doi: 10.1016/s0035-3787(07)90354-9. Rev Neurol (Paris). 2007. PMID: 17304172 Review. French.
Cited by
-
Targeting Pathogenic Lafora Bodies in Lafora Disease Using an Antibody-Enzyme Fusion.Cell Metab. 2019 Oct 1;30(4):689-705.e6. doi: 10.1016/j.cmet.2019.07.002. Epub 2019 Jul 25. Cell Metab. 2019. PMID: 31353261 Free PMC article.
-
Lafora disease: epidemiology, pathophysiology and management.CNS Drugs. 2010 Jul;24(7):549-61. doi: 10.2165/11319250-000000000-00000. CNS Drugs. 2010. PMID: 20527995 Review.
-
Lafora Disease Masquerading as Hepatic Dysfunction.Cureus. 2018 Aug 24;10(8):e3197. doi: 10.7759/cureus.3197. Cureus. 2018. PMID: 30498646 Free PMC article.
-
Lafora Disease during a Seven-Year Period, Bosnian and Herzegovinian experience.Iran J Child Neurol. 2019 Winter;13(1):115-120. Iran J Child Neurol. 2019. PMID: 30598679 Free PMC article.
-
Lafora disease: Current biology and therapeutic approaches.Rev Neurol (Paris). 2022 Apr;178(4):315-325. doi: 10.1016/j.neurol.2021.06.006. Epub 2021 Jul 21. Rev Neurol (Paris). 2022. PMID: 34301405 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources